AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Strategic Alternatives
How to Build and Sell a Biotech in 2024
Jul 8, 2024
CEOs who sold biotechs worth $29bn share insights on M&A. They discuss building strong organizations, understanding value, navigating FTC regulations, analyzing legal principles, and strategic considerations for biotech M&A in 2024.
35:19
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Successful biotech company building involves focusing on operational excellence and team confidence.
- Biopharma M&A success requires understanding buyer perspectives, competitive processes, and revenue generation timelines.
Deep dives
Keys to Successfully Build and Sell a Biotech Company
Building and selling a biotech company involves strategic value creation paths, including standalone development and potential mergers and acquisitions (M&A). CEOs shared insights on focusing on building a great company, having a commercial mindset, and avoiding speculation about M&A to avoid destroying value. They highlighted the importance of operational excellence, developing necessary functions, and building confidence in the management team.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode